Stericycle (NASDAQ:SRCL – Get a score) issued an update on its fiscal 2022 earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of $2.00 to $2.15 for the period, compared to with the consensus estimate at $2.07. The company issued revenue guidance of -.
Wall Street analysts weigh in
Several equities research analysts have rated the company. Barrington Research reiterated a market perform rating on shares of Stericycle in a report on Tuesday, April 19th. TheStreet lowered Stericycle from an ac rating to a d+ rating in a report on Thursday, May 12th. Robert W. Baird reduced their target price on Stericycle from $72.00 to $63.00 in a report on Friday, April 29th. Berenberg Bank downgraded Stericycle from a buy rating to a hold rating and cut their price target for the stock from $95.00 to $46.00 in a report on Thursday, May 12th. They pointed out that the move was a valuation call. Finally, StockNews.com lowered Stericycle from a buy rating to a hold rating in a report on Thursday, April 21st. Four investment analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. The stock currently has an average rating of Hold and a consensus price target of $58.67, according to MarketBeat.com.
Stericycle stock 6.9%
Daily advertising investment
27 US Cities Where Stocks Are Returning 26% Annually
What are the highest performing stocks you’ve ever owned? The dividends on these stocks have grown so rapidly over the years that they are now giving us an average of 26%! When you start getting 26% of your money, your financial problems tend to pretty much evaporate.
Shares of Stericycle stock traded up $3.28 during midday trading on Friday, reaching $50.53. The stock had a trading volume of 840,416 shares, compared to its average volume of 449,582. The company has a market cap of $4.65 billion, a PE ratio of -68.20, a price-to-earnings-growth ratio of 2.97 and a beta of 1.30. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.92, and a current ratio of 0.92. Stericycle has a fifty-two week low of $40.35 and a fifty-two week high of $72.11. The stock’s 50-day simple moving average is $45.31, and its 200-day simple moving average is $51.81.
Stericycle (NASDAQ:SRCL – Get a score) last announced its results on Friday, August 5. The business services provider reported $0.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.44 by $0.04. The company had revenue of $679.80 million during the quarter, compared to analysts’ expectations of $678.27 million. Stericycle had a positive return on equity of 6.84% and a negative net margin of 2.58%. Stericycle’s quarterly revenue was up 1.1% on a year-over-year basis. During the same quarter last year, the company posted earnings per share of $0.67. On average, sell-side analysts forecast that Stericycle will post 2.04 EPS for the current fiscal year.
Institutional inputs and outputs
Several hedge funds have recently modified their holdings of SRCL. Ancora Advisors LLC bought a new position in Stericycle during the first quarter worth $34,000. Covestor Ltd boosted its position in Stericycle by 117.2% in the first quarter. Covestor Ltd now owns 1,553 shares of the business services provider’s stock worth $92,000 after purchasing an additional 838 shares in the last quarter. Echo Street Capital Management LLC bought a new position in Stericycle during the first quarter worth $261,000. Cetera Advisor Networks LLC boosted its position in Stericycle by 11.3% in the first quarter. Cetera Advisor Networks LLC now owns 4,834 shares of the business services provider’s stock worth $285,000 after buying an additional 490 shares during the last quarter. Finally, KB Financial Partners LLC boosted its position in Stericycle by 13.7% during the first quarter. KB Financial Partners LLC now owns 8,878 shares of the business services provider’s stock worth $523,000 after purchasing an additional 1,070 shares during the last quarter. Hedge funds and other institutional investors own 99.89% of the company’s shares.
Stericycle Company Profile
Stericycle, Inc, together with its subsidiaries, provides regulatory and compliance solutions in the United States, Europe and internationally. The company offers regulated waste and compliance services, including management and sharps management solutions; pharmaceutical waste services; hazardous waste disposal; marine waste services, such as port and airport waste; and compliance programs under the Steri-Safe, Clinical Services, First Practice Management, SeguriMed and EnviroAssure brands.
Read more
This instant news alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reporting. This story was reviewed by the MarketBeat editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Stericycle, you’ll want to hear this.
MarketBeat tracks Wall Street’s top-rated and top-performing research analysts and the stocks they recommend to their clients daily. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market takes notice … and Stericycle wasn’t on the list.
Although Stericycle currently has a “Hold” rating among analysts, the top rated analysts believe these five stocks are best buys.
Check out the five stocks here
[ad_2]
Source link
